CSO, chief scientific officer
Dr. Khazak is an experienced biologist with more than 15 years of working in multiple biopharmaceutical companies. He is co-founder and CSO of NexusPharma, heading biology research and development.
Dr Astsaturov is a MD, PhD scientific advisory board member of NexusPharma and a physician at FCCC. His clinical expertise is in gastrointestinal cancers including pancreatic, colorectal, and liver cancer.
Dr. Erica Golemis is a scientific advisory board member of NexusPharma. Erica is Deputy Chief Scientific Officer planning the future of cancer research at Fox Chase Cancer Center.
We are supported by a highly regarded international network of scientific collaborators, development experts, and other expert advisors, enabling a “virtual” development framework with:
Specific biological expertise at universities and institutions such as the University of North Carolina at Chapel Hill, the University of California at Los Angeles, the University of Pennsylvania, as well as the University of Munich, Germany
Collaborations on animal models and further drug development through the National Cancer Institute
Animal pharmacokinetic and pharmacodynamic studies, and custom medicinal chemistry, through contract research organizations (CROs)